ロード中...
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification
BACKGROUND: c-Met is the receptor tyrosine kinase for hepatocyte growth factor (HGF) encoded by the MET proto-oncogene. Aberrant activation of c-Met resulting from MET amplification and c-Met overexpression is associated with poor clinical outcome in multiple malignancies underscoring the importance...
保存先:
出版年: | BMC Cancer |
---|---|
主要な著者: | , , , , , , , , , , , , , , , , , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
BioMed Central
2016
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4755020/ https://ncbi.nlm.nih.gov/pubmed/26879245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2138-z |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|